Risk factors for early recurrent Clostridium difficile -: Associated diarrhea

被引:63
作者
Do, AN
Fridkin, SK
Yechouron, A
Banerjee, SN
Killgore, GE
Bourgault, AM
Jolivet, M
Jarvis, WR
机构
[1] Ctr Dis Control & Prevent, Hosp Infect Program, Atlanta, GA 30333 USA
[2] Hop St Luc, Montreal, PQ H2X 1P1, Canada
[3] Ctr Hosp Argrignon, Verdun, PQ, Canada
关键词
D O I
10.1086/513952
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
Recurrence is a common sequela of Clostridium difficle-associated diarrhea (CDD) and may increase morbidity, costs, and treatment-related antimicrobial resistance. Because recurrent CDD (RCDD) frequently occurs very soon after an initial episode, our goal was to determine the risk factors for early RCDD (occurring less than or equal to 45 days after the initial episode). We conducted a case-control study, comparing 13 patients with early RCDD (case patients) with 46 patients who had only one CDD episode (control patients) at Centre Hospitalier Angrignon (Quebec) during January 1993 through November 1994. Risk factors for early RCDD included a history of chronic renal insufficiency, a white blood cell count of greater than or equal to 15 x 10(3)/mm(3), and community-acquired diarrhea with the first CDD episode. For seven of eight case patients, C. difficile strains from the first and second CDD episodes were identical, suggesting that relapse is more common than reinfection. These results suggest that treatments should be directed at preventing relapses in patients at high risk for early RCDD.
引用
收藏
页码:954 / 959
页数:6
相关论文
共 38 条
[1]
Allen SD, 1991, MANUAL CLIN MICROBIO, P505
[2]
[Anonymous], 1994, EPI INFO VERSION 6 W
[3]
CLOSTRIDIUM-DIFFICILE-ASSOCIATED DIARRHEA IN UREMIC PATIENTS [J].
ARONSSON, B ;
BARANY, P ;
NORD, CE ;
NYSTROM, B ;
STENVINKEL, P .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1987, 6 (03) :352-356
[4]
ISCHEMIC COLITIS IN CHRONIC UREMIA [J].
AUBIA, J ;
LLOVERAS, J ;
MUNNE, A ;
SOLSONA, J ;
MASRAMON, J ;
ORFILA, MA ;
RIAMBAU, E ;
SERRANO, S ;
LLORACH, M .
NEPHRON, 1981, 29 (3-4) :146-150
[5]
CLOSTRIDIUM-DIFFICILE - HISTORY OF ITS ROLE AS AN ENTERIC PATHOGEN AND THE CURRENT STATE OF KNOWLEDGE ABOUT THE ORGANISM [J].
BARTLETT, JG .
CLINICAL INFECTIOUS DISEASES, 1994, 18 :S265-S272
[6]
THERAPY OF RELAPSING CLOSTRIDIUM-DIFFICILE ASSOCIATED DIARRHEA AND COLITIS WITH THE COMBINATION OF VANCOMYCIN AND RIFAMPIN [J].
BUGGY, BP ;
FEKETY, R ;
SILVA, J .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 1987, 9 (02) :155-159
[7]
IMMUNE POTENTIAL IN HUMAN UREMIA .1. RELATIONSHIP OF GLOMERULAR-FILTRATION RATE TO DEPRESSION OF IMMUNE POTENTIAL [J].
BYRON, PR ;
MALLICK, NP ;
TAYLOR, G .
JOURNAL OF CLINICAL PATHOLOGY, 1976, 29 (09) :765-769
[8]
CARTER D, 1965, J EXP MED, V123, P251
[9]
A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[10]
FUSIDIC ACID FOR THE TREATMENT OF ANTIBIOTIC-ASSOCIATED COLITIS INDUCED BY CLOSTRIDIUM-DIFFICILE [J].
CRONBERG, S ;
CASTOR, B ;
THOREN, A .
INFECTION, 1984, 12 (04) :276-279